COR-OTICIN Drug Patent Profile
✉ Email this page to a colleague
When do Cor-oticin patents expire, and when can generic versions of Cor-oticin launch?
Cor-oticin is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in COR-OTICIN is hydrocortisone acetate; neomycin sulfate. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; neomycin sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COR-OTICIN?
- What are the global sales for COR-OTICIN?
- What is Average Wholesale Price for COR-OTICIN?
Summary for COR-OTICIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 4,462 |
| DailyMed Link: | COR-OTICIN at DailyMed |
US Patents and Regulatory Information for COR-OTICIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | COR-OTICIN | hydrocortisone acetate; neomycin sulfate | SUSPENSION/DROPS;OPHTHALMIC | 060188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
